Vimarsana
Biggest News Aggregation in the World

Page 9 - Consensus Estimates News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Consensus Estimates. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Consensus Estimates Today - Breaking & Trending Today

Earnings Beat: Arhaus, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Vimarsana News

Earnings Beat: Arhaus, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Shareholders of Arhaus, Inc. ( NASDAQ:ARHS ) will be pleased this week, given that the stock price is up 14% to...

Source: yahoo.com
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates - Vimarsana News

Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) Just Reported Annual Earnings And Analysts Are Lifting Their Estimates

There's been a notable change in appetite for Recursion Pharmaceuticals, Inc. ( NASDAQ:RXRX ) shares in the week since...

Source: yahoo.com
Earnings Beat: Dillard's, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Vimarsana News

Earnings Beat: Dillard's, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models

Last week, you might have seen that Dillard's, Inc. ( NYSE:DDS ) released its yearly result to the market. The early...

Source: yahoo.com
Analysts Have Just Cut Their Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Revenue Estimates By 51% - Vimarsana News

Analysts Have Just Cut Their Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Revenue Estimates By 51%

The latest analyst coverage could presage a bad day for Aclaris Therapeutics, Inc. ( NASDAQ:ACRS ), with the analysts...

Source: yahoo.com
Fate Therapeutics, Inc. (NASDAQ:FATE) Just Reported And Analysts Have Been Lifting Their Price Targets - Vimarsana News

Fate Therapeutics, Inc. (NASDAQ:FATE) Just Reported And Analysts Have Been Lifting Their Price Targets

It's been a good week for Fate Therapeutics, Inc. ( NASDAQ:FATE ) shareholders, because the company has just released...

Source: yahoo.com